|

Mid-day market update: ProPetro slides after Q4 results; InflaRx shares jump

Midway through trading Wednesday, the Dow traded down 2.67% to 21331.51 while the NASDAQ fell 2.33% to 7,520.78. The S&P also fell, dropping 2.99% to 2,507.22.

The U.S. is now the epicenter of the coronavirus pandemic with the highest number of cases around the world. The White House officials project the country's death toll from coronavirus to range between 100,000 and 240,000. U.S. reported a total of 189,600 coronavirus cases with around 4,000 deaths. Italy reported a total of at least 105,700 confirmed cases and 12,400 deaths, while Spain confirmed a total of over 102,100 coronavirus cases. Mainland China reported 36 new cases on Tuesday. In total, there are at least 873,700 cases of COVID-19 worldwide with over 43,200 deaths, according to data compiled by Johns Hopkins University.

Leading and Lagging Sectors

Consumer staples shares slipped by just 0.8% on Wednesday. Meanwhile, top gainers in the sector included Landec Corporation LNDC 7.19%, up 8%, and British American Tobacco p.l.c. BTI 3.63%, up 5%.

In trading on Wednesday, real estate shares dipped 7.3%.

Top Headline

UniFirst Corp UNF 5.25% reported upbeat results for second quarter.

UniFirst reported quarterly earnings of $1.82 per share, which beat the analyst consensus estimate of $1.65 per share. The company reported quarterly sales of $464.6 million, which exceeded the analyst consensus estimate of $457.48 million.

Equities Trading UP

InflaRx N.V. IFRX 42.28% shares shot up 42% to $5.42 after the company said it has enrolled and dosed the first patient into a randomized clinical trial investigating the safety and efficacy of IFX-1, its monoclonal anti-C5a antibody in patients with severe COVID-19-induced pneumonia. The trial is being initiated in the Netherlands.

Shares of Chembio Diagnostics, Inc. CEMI 36.52% got a boost, shooting 29% to $6.60 after the company said it has launched in the U.S. the rapid DPP COVID-19 serological point-of-care test for the detection of IgM and IgG antibodies.

Safe-T Group Ltd SFET 131.1% shares were also up, gaining 46% to $2.3913 after reporting Q4 results. Revenue for the three-month period ended December 31, 2019 surged 141% year-over-year to $1,114,000.

Equities Trading DOWN

VIVUS, Inc. VVUS 58.33% shares tumbled 58% to $1.53. VIVUS priced its 7.22 million share common stock offering at $1.60 per share.

Shares of ProPetro Holding Corp. PUMP 15.54% were down 16% to $2.10 following Q4 results. The company’s net income declined 34% from the previous quarter to $22.7 million, while revenue dropped to $434.8 million from $541.8 million in the third quarter.

Immunomedics, Inc. IMMU 23.55% was down, falling 19% to $10.91 amid market weakness as growing coronavirus concerns in the US weigh on equities.

Commodities

In commodity news, oil traded down 0.2% to $20.43, while gold traded up 0.3% to $1,600.60.

Silver traded down 0.1% Wednesday to $14.155, while copper fell 2.1% to $2.1805.

Euro zone

European shares were lower today. The eurozone’s STOXX 600 fell 2.3% the Spanish Ibex Index fell 2.4%, while Italy’s FTSE MIB Index declined 2.3%. Meanwhile, the German DAX dropped 3.3%, and the French CAC 40 fell 3.5% while UK shares fell 3.7%.

Economics

The Automatic Data Processing Inc. reported that private sector employment declined by 27,000 in March, versus economists’ expectations for a drop of 180,000 jobs.

The IHS Markit manufacturing PMI declined to 48.5 in March, versus a preliminary reading of 49.2.

The ISM manufacturing PMI dropped to 49.1 in March, versus a reading of 50.1 in February.

U.S. construction spending fell 1.3% in February, versus a revised 2.8% increase in January.

U.S. crude supplies climbed 13.8 million barrels for the week ended March 27, the Energy Information Administration reported. However, analysts were expecting a gain of 4.6 million barrels. Gasoline supplies rose 7.5 million barrels, while distillate supplies slipped 2.2 million barrels last week.

Author

Benzinga Team

Benzinga's news desk is a dynamic and innovative team that provides real-time, actionable articles that help readers navigate the market.

More from Benzinga Team
Share:

Editor's Picks

EUR/USD faces some resistance near 100-SMA on H4, around 1.1830 zone

The EUR/USD pair gains some follow-through positive traction for the second consecutive day and climbs to the 1.1830 region during the Asian session on Thursday. The US Dollar remains on the back foot amid concerns about the economic fallout from US President Donald Trump's erratic trade policies and acts as a tailwind for spot prices.

GBP/USD extends recovery to near 20-day EMA as US Dollar weakens

The Pound Sterling holds onto weekly gains around 1.3565 against the US Dollar during the Asian trading session on Thursday. The GBP/USD pair trades firmly as the US Dollar remains under pressure due to uncertainty surrounding the United States trade policy outlook.

Gold looks to build on strength beyond $5,200, eyes monthly peak amid safe-haven flows

Gold touches a fresh daily high heading into the European session on Thursday, with bulls looking to build on the momentum beyond the $5,200 mark. This marks the second straight day of a positive move and is supported by sustained safe-haven flows, bolstered by uncertainties surrounding US President Donald Trump's trade policies and US-Iran nuclear talks.

Stellar: Relief bounce fades as bearish undertone persists

Stellar is trading around $0.16 at the time of writing on Thursday after rebounding more than 8% in the previous day. Derivatives data paints a negative picture as XLM’s short bets hit a monthly high while Open Interest continues to decline.

Nvidia delivers another monster earnings report, and forecasts big things to come

It was another monster earnings report from Nvidia for fiscal Q4. Revenues were $68.1bn, smashing estimates of $65bn. Gross profit margin was a healthy 75%, up from 73.5% in the prior quarter, and the outlook for this quarter was monstrous.

Solana strikes key resistance with double-digit gains

Solana trades at $88 at press time on Thursday, after an 11% upswing the previous day within a broader consolidation range of roughly three weeks. Institutional demand for Solana heightens as US spot SOL Exchange Traded Funds record $30 million of inflow on Wednesday.